New Jersey 2026-2027 Regular Session

New Jersey Senate Bill S4213

Caption

Requires DOH to develop and maintain centralized neurodegenerative disorders database.

Summary

This bill requires the New Jersey Department of Health to develop and maintain a centralized public database on neurodegenerative disorders. The database must cover conditions such as amyotrophic lateral sclerosis (ALS), Huntington’s disease, Parkinson’s disease, Alzheimer’s disease, related dementias, and other prevalent neurodegenerative disorders as determined by the Commissioner of Health. The database would compile State and national statistics and information on causes and nature of these disorders, including environmental and hereditary factors, diagnostic procedures, symptoms, treatment, and life expectancy. It would also include information about the State’s professional workforce, current providers and treatment centers specializing in diagnosis and treatment, and any other relevant information identified by the commissioner. The information must be made available to the public on the Department of Health website in a searchable format.

Impact

The bill would add a new responsibility to the Department of Health under Title 26 of the Revised Statutes: creating, maintaining, and updating a centralized online resource on neurodegenerative disorders. It does not create a new regulatory program for patients or providers, but it would require the department to collect, organize, and publish health data and provider information, and to adopt implementing regulations under the Administrative Procedure Act. The main affected parties would be the Department of Health, health care providers and treatment centers specializing in neurodegenerative disorders, and members of the public seeking information about these conditions.

Sentiment

Based on the bill text and the absence of recorded committee testimony or votes in the provided materials, the bill appears to be informational and public-health oriented rather than controversial. Its stated purpose suggests likely support from advocates for patients, caregivers, and researchers who would benefit from a centralized source of reliable information. No opposition or divided vote is reflected in the available record.

Contention

No specific points of contention are documented in the provided materials because there are no committee transcripts or recorded votes. Potential areas of debate, if raised later, could include the administrative burden on the Department of Health, the scope of disorders included, the cost of maintaining current data, and how provider/workforce information would be collected and updated. The bill gives the Commissioner of Health discretion to determine additional disorders and relevant information, which could also be a point of discussion.

Companion Bills

No companion bills found.

Similar Bills

CA SB1047

Neurodegenerative disease registry program.

PA HB704

Establishing the Neurodegenerative Disease Research Program and the Neurodegenerative Disease Research Program Fund; and imposing duties on the Department of Health.

US HB7779

HEALTHY BRAINS Act of 2026 Harmonizing Environmental Analyses and Launching Therapeutic Hubs to Yield Bolstered Research And Innovation in Neurological Science Act of 2026

TX SB1525

Relating to prior authorization for prescription drug benefits related to the treatment of neurodegenerative diseases.

CA AB829

An act to add and repeal Article 1 (commencing with Section 18700) of Chapter 3 of Part 10.

IL SB3804

DPH-NEURO DISEASE PROGRESS ACT

IL HB5465

DPH-NEURO DISEASE PROGRESS ACT

FL S1784

PSP Awareness Month